Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 396-402

  Thatcher, N ^a   De Campos, E S ^a   Bell, D R ^b   Steward, W P ^c   Varghese, G ^d   Morant, R ^e   Vansteenkiste, J F ^f   Rosso, R ^g   Ewers, S B ^h   Sundal, E ⁱ   Schatzmann, E ^j   Stocker, H ^j  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b Royal North Shore and Mater Hospitals   (Australia)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d BELFAST CITY HOSPITAL   (United Kingdom)

^e CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Medical Oncology   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ Janssen Cilag   (Norway)

^j JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

more..

Author keywords

Epoetin prevents chemotherapy SCLC anaemia

Indexed keywords

HEMOGLOBIN; PLATINUM; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032927104     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690369     Document Type: Article

References (24)

1. Abels R (1993) Erythropoietin for anaemia in cancer patients. Eur J Cancer 29A: S2-8
2. Baer AN, Dessypris E, Goldwasser E and Krantz SB (1987) Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 66: 559-564
3. Blumberg N and Heal JM (1994) Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med 118: 371-379
4. Canetta R, Rosencweig M and Carter SK (1985) Carboplatin: the clinical spectrum to date. Cancer Treat Rev 12: 125-136
5. Cascinu S, Fedeli A, Fedeli SL and Catalano G (1993) Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. Br J Cancer 67: 156-158
6. Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keuer AM, Kugler JW, Nichols CR, Salmon SE, Silver RT, Storniolo AM, Wampler GL, Dooley CM, Larholt KM, Nelson RA and Abels RI (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85: 801-806
7. de Campos E, Radford J, Steward W, Milroy R, Dougal M, Swinden R, Testa N and Thatcher N (1995) Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small cell lung cancer. J Clin Oncol 13: 1623-1631
8. Del Mastro L, Venturini M, Lionetto R, Garrone O, Melioli G, Pasquetti W, Sertoli MR, Bertelli G, Canavese G, Constantini M and Rosso R (1997) Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol 15: 2715-2721
9. Eschbach JW, Egrie JC, Downing MR, Browne JK and Adamson JW (1978) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316: 73-78
10. Gebbia V, Valenza R and Rausa L (1990) The in vitro effect of recombinant erythropoietin on cisdiamminodichloroplatinum-induced inhibition of murine erythroid stem cells. Anticancer Res 10: 1779-1782
11. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S and Vadhan-Raj S (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice Procrit Study Group. J Clin Oncol 15: 1218-1234
12. Henry DH, Rudnick SA, Bryant E, Adels RI, Danna RP, Staddon AP and Mason BA (1989) Preliminary report of two double-blind, placebo-controlled studies using human recombinant erythropoietin (r-HuEPO) in the anemia associated with cancer. Blood 74: 6a
13. Hesketh PJ, Cooley TP, Finkel HE, Wright J and Hesketh AM (1988) Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil and mitomycin C. Cancer 62: 1466-1470
14. Kaye SB, Lewis CR, Paul J, Duncan ID, Gordon HK, Kitchener HC, Cruickshank DJ, Atkinson RJ, Soukop M, Rankin EM, Cassidy J, Davis JA, Reed NS, Crawford SM, MacLean A, Swapp GA, Sarkar TK, Kennedy JH and Symonds RP (1992) Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet 340: 329-333
15. Kuzur ME and Greco FA (1980) Cisplatin-induced anemia. N Engl J Med 303: 110-111
16. Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H and Barnas U (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322: 1693-1699
17. Ludwig H, Leitgeb C, Fritz E, Krainer M, Kuhrer I, Kornek G, Sagaster P and Weissmann A (1993a) Erythropoietin treatment of chronic anaemia of cancer. Eur J Cancer 29A: S8-12
18. Ludwig H, Pecherstorfer M, Leitgeb C and Fritz E (1993b). Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma. Stem Cells 11: 348-355
19. Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
20. Miller CB, Jones RJ, Piantadosi S, Abeloff MD and Spivak JL (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322: 1689-1692
21. Radermacher J and Koch KM (1993) Erythropoietin and hypertension. In Erythropoietin: Molecular Physiology and Clinical Applications, Bauer C, Koch KM, Scigella P, et al (eds), pp. 129-152. Marcel Dekker: New York
22. Rothmann SA, Paul P, Weick JK, McIntyre WR and Fantelli F (1985) Effect of cisdiamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells. Int J Cell Cloning 3: 415-423
23. Skillings JR, Sridhar FG, Wong C and Paddock L (1993) The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol 16: 22-25
24. Walker RH (1987) Special report: transfusion risks. Am J Clin Pathol 88: 374-378